It continues to be one of the top choices for new MS patients treated by the top* MS docs here. IMO, more people should be taking Tysabri.
I suspect it will take something very significant to upset the Copaxone share. BG12 IF priced close (unlikely) to Copaxone could do it.
ij
* Researchers and thought leaders.
It is astonishing what foolish things one can temporarily believe if one thinks too long alone ... where it is often impossible to bring one's ideas to a conclusive test either formal or experimental. J.M. Keynes
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.